{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:46:07Z","timestamp":1777941967596,"version":"3.51.4"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","award":["212969\/Z\/18\/Z"],"award-info":[{"award-number":["212969\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Structural Genomics Consortium","award":["1097737"],"award-info":[{"award-number":["1097737"]}]},{"name":"UNC Eshelman School of Pharmacy and Cancer Research UK"},{"DOI":"10.13039\/501100000027","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR210007"],"award-info":[{"award-number":["RR210007"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000092","name":"Ontario Genomics Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008658","name":"German Cancer Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008658","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frankfurt Cancer Institute","award":["875510"],"award-info":[{"award-number":["875510"]}]},{"name":"European Union's Horizon 2020"},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","award":["C309\/A11566"],"award-info":[{"award-number":["C309\/A11566"]}],"id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","award":["C2739\/A22897"],"award-info":[{"award-number":["C2739\/A22897"]}],"id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009272","name":"Chordoma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mark Foundation","award":["C35696\/A23187"],"award-info":[{"award-number":["C35696\/A23187"]}]},{"name":"Wellcome Trust Sir Henry Wellcome Postdoctoral Fellowship","award":["204735\/Z\/16\/Z"],"award-info":[{"award-number":["204735\/Z\/16\/Z"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We describe the Chemical Probes Portal (https:\/\/www.chemicalprobes.org\/), an expert review-based public resource to empower chemical probe assessment, selection and use. Chemical probes are high-quality small-molecule reagents, often inhibitors, that are important for exploring protein function and biological mechanisms, and for validating targets for drug discovery. The publication, dissemination and use of chemical probes provide an important means to accelerate the functional annotation of proteins, the study of proteins in cell biology, physiology, and disease pathology, and to inform and enable subsequent pioneering drug discovery and development efforts. However, the widespread use of small-molecule compounds that are claimed as chemical probes but are lacking sufficient quality, especially being inadequately selective for the desired target or even broadly promiscuous in behaviour, has resulted in many erroneous conclusions in the biomedical literature. The Chemical Probes Portal was established as a public resource to aid the selection and best-practice use of chemical probes in basic and translational biomedical research. We describe the background, principles and content of the Portal and its technical development, as well as examples of its applications and use. The Chemical Probes Portal is a community resource and we therefore describe how researchers can be involved in its content and development.<\/jats:p>","DOI":"10.1093\/nar\/gkac909","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T10:53:11Z","timestamp":1666349591000},"page":"D1492-D1502","source":"Crossref","is-referenced-by-count":53,"title":["The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1634-9034","authenticated-orcid":false,"given":"Albert A","family":"Antolin","sequence":"first","affiliation":[{"name":"Division of Cancer Therapeutics, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Department of Data Science, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8908-0347","authenticated-orcid":false,"given":"Domenico","family":"Sanfelice","sequence":"additional","affiliation":[{"name":"Division of Cancer Therapeutics, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Department of Data Science, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisa","family":"Crisp","sequence":"additional","affiliation":[{"name":"Division of Cancer Therapeutics, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Department of Data Science, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloy","family":"Villasclaras\u00a0Fernandez","sequence":"additional","affiliation":[{"name":"Division of Cancer Therapeutics, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Department of Data Science, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioan L","family":"Mica","sequence":"additional","affiliation":[{"name":"Division of Cancer Therapeutics, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Department of Data Science, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Cancer Therapeutics, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Department of Data Science, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Collins","sequence":"additional","affiliation":[{"name":"Division of Cancer Therapeutics, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Centre for Cancer Drug Discovery, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aled","family":"Edwards","sequence":"additional","affiliation":[{"name":"Structural Genomics Consortium, University of Toronto , Toronto , ON M5G 1L7 , Canada"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-4157","authenticated-orcid":false,"given":"Susanne","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Chemistry, Goethe University Frankfurt , Frankfurt , 60438, Germany"},{"name":"Structural Genomics Consortium, BMLS, Goethe University Frankfurt , Frankfurt , 60438 , Germany"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3367-2519","authenticated-orcid":false,"given":"Bissan","family":"Al-Lazikani","sequence":"additional","affiliation":[{"name":"Department of Genomics Medicine and the Institute of Data Science in Oncology, MD Anderson Cancer Center , Houston , TX , 77054 , USA"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1659-3034","authenticated-orcid":false,"given":"Paul","family":"Workman","sequence":"additional","affiliation":[{"name":"Division of Cancer Therapeutics, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Centre for Cancer Drug Discovery, The Institute of Cancer Research , London , SM2 5NG , UK"},{"name":"Chemical Probes Portal , www.chemicalprobes.org"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"2023010804341813100_B1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem. J."},{"key":"2023010804341813100_B2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nchembio1207-739","article-title":"Recognizing and exploiting differences between RNAi and small-molecule inhibitors","volume":"3","author":"Weiss","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"2023010804341813100_B3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.chembiol.2010.05.013","article-title":"Probing the probes: fitness factors for small molecule tools","volume":"17","author":"Workman","year":"2010","journal-title":"Chem. Biol."},{"key":"2023010804341813100_B4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nchembio.296","article-title":"The art of the chemical probe","volume":"6","author":"Frye","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"2023010804341813100_B5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nchembio.1197","article-title":"Target validation using chemical probes","volume":"9","author":"Bunnage","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"2023010804341813100_B6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coph.2014.07.007","article-title":"Chemical biology approaches to target validation in cancer","volume":"17","author":"Blagg","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"2023010804341813100_B7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.chembiol.2015.11.011","article-title":"The impact of chemical probes in drug discovery: a pharmaceutical industry perspective","volume":"23","author":"Garbaccio","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"2023010804341813100_B8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccell.2017.06.005","article-title":"Choose and use your chemical probe wisely to explore cancer biology","volume":"32","author":"Blagg","year":"2017","journal-title":"Cancer Cell"},{"key":"2023010804341813100_B9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrd.2018.53","article-title":"Chemical probes and drug leads from advances in synthetic planning and methodology","volume":"17","author":"Gerry","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023010804341813100_B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1039\/9781839160745-00001","article-title":"CHAPTER 1: Introduction to chemical probes","volume-title":"The Discovery and Utility of Chemical Probes in Target Discovery","author":"Wagner","year":"2020"},{"key":"2023010804341813100_B11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome: international human genome sequencing consortium","volume":"409","author":"International Human Genome Sequencing Consortium","year":"2001","journal-title":"Nature"},{"key":"2023010804341813100_B12","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The sequence of the human genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science"},{"key":"2023010804341813100_B13","doi-asserted-by":"crossref","first-page":"180241","DOI":"10.1098\/rsob.180241","article-title":"Hidden in plain sight: what remains to be discovered in the eukaryotic proteome","volume":"9","author":"Wood","year":"2019","journal-title":"Open Biol."},{"key":"2023010804341813100_B14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41587-022-01316-z","article-title":"An open invitation to the understudied proteins initiative","volume":"40","author":"Kustatscher","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"2023010804341813100_B15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/470163a","article-title":"Too many roads not taken","volume":"470","author":"Edwards","year":"2011","journal-title":"Nature"},{"key":"2023010804341813100_B16","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1038\/s41467-022-31271-x","article-title":"A conversation on using chemical probes to study protein function in cells and organisms","volume":"13","year":"2022","journal-title":"Nat. Commun."},{"key":"2023010804341813100_B17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4155\/fmc-2019-0231","article-title":"Public resources for chemical probes: the journey so far and the road ahead","volume":"13","author":"Antolin","year":"2021","journal-title":"Future Med. Chem."},{"key":"2023010804341813100_B18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nchembio.1867","article-title":"The promise and peril of chemical probes","volume":"11","author":"Arrowsmith","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"2023010804341813100_B19","article-title":"Biochemists launch crowdsourcing site to combat bad data","author":"Service","year":"2015","journal-title":"Science"},{"key":"2023010804341813100_B20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1039\/D1MD00228G","article-title":"Target 2035-update on the quest for a probe for every protein","volume":"13","author":"M\u00fcller","year":"2022","journal-title":"RSC Med. Chem."},{"key":"2023010804341813100_B21","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/nar\/gkaa1059","article-title":"canSAR: update to the cancer translational research and drug discovery knowledgebase","volume":"49","author":"Mitsopoulos","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804341813100_B22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1021\/acschembio.1c00036","article-title":"The promise and peril of chemical probe negative controls","volume":"16","author":"Lee","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"2023010804341813100_B23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/513481a","article-title":"Chemical con artists foil drug discovery","volume":"513","author":"Baell","year":"2014","journal-title":"Nature"},{"key":"2023010804341813100_B24","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","article-title":"Physiochemical drug properties associated with in vivo toxicological outcomes","volume":"18","author":"Hughes","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2023010804341813100_B25","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1021\/acs.jmedchem.7b00229","article-title":"The ecstasy and agony of assay interference compounds","volume":"60","author":"Aldrich","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/51\/D1\/D1492\/48441615\/gkac909.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/51\/D1\/D1492\/48441615\/gkac909.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T04:39:26Z","timestamp":1673152766000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/51\/D1\/D1492\/6765313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":25,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2022,10,21]]},"published-print":{"date-parts":[[2023,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkac909","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,6]]},"published":{"date-parts":[[2022,10,21]]}}}